|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-18
|
|
pubmed:abstractText |
This study investigated the efficacy and adverse effects of pegylated interferon (Peg-IFN) plus ribavirin therapy in aged patients with chronic hepatitis C (CH-C).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:FukuiHiroyukiH,
pubmed-author:HagiwaraHidekiH,
pubmed-author:HayashiNorioN,
pubmed-author:HijiokaTaizoT,
pubmed-author:HiramatsuNaokiN,
pubmed-author:ImaiYasuharuY,
pubmed-author:InadaMasamiM,
pubmed-author:InoueAtsuoA,
pubmed-author:InuiYoshiakiY,
pubmed-author:ItoToshifumiT,
pubmed-author:KantoTatsuyaT,
pubmed-author:KasaharaAkinoriA,
pubmed-author:KatoMichioM,
pubmed-author:KaytayamaKazuhiroK,
pubmed-author:KisoShinichiS,
pubmed-author:MitaEijiE,
pubmed-author:MiyagiTakuyaT,
pubmed-author:MochizukiKiyoshiK,
pubmed-author:OshitaMasahideM,
pubmed-author:OzeTsugikoT,
pubmed-author:TakeharaTetsuoT,
pubmed-author:TamuraShinjiS,
pubmed-author:TatsumiTomohideT,
pubmed-author:YakushijinTakayukiT,
pubmed-author:YoshidaYuichiY,
pubmed-author:YoshiharaHarumasaH
|
|
pubmed:copyrightInfo |
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
604-11
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21145907-Adult,
pubmed-meshheading:21145907-Age Factors,
pubmed-meshheading:21145907-Aged,
pubmed-meshheading:21145907-Antiviral Agents,
pubmed-meshheading:21145907-Cohort Studies,
pubmed-meshheading:21145907-Drug Therapy, Combination,
pubmed-meshheading:21145907-Female,
pubmed-meshheading:21145907-Genotype,
pubmed-meshheading:21145907-Hepacivirus,
pubmed-meshheading:21145907-Hepatitis C, Chronic,
pubmed-meshheading:21145907-Humans,
pubmed-meshheading:21145907-Interferon-alpha,
pubmed-meshheading:21145907-Male,
pubmed-meshheading:21145907-Middle Aged,
pubmed-meshheading:21145907-Polyethylene Glycols,
pubmed-meshheading:21145907-RNA, Viral,
pubmed-meshheading:21145907-Recombinant Proteins,
pubmed-meshheading:21145907-Retrospective Studies,
pubmed-meshheading:21145907-Ribavirin,
pubmed-meshheading:21145907-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.
|
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
